The current invention has a unique feature that allows effective use of urinal waste to produce electric energy by Mass Flow Controller (MCF). In earlier days, some researchers attempted to integrate MFCs with Urinal systems. However, there is a gap in field trial studies describing pilot-scale MFC systems deployed under real conditions. The present invention has overcome those challenges to make the MFC based Urinal System scalable at large scale.

Patent Application Number: 201911005010

For More details about the technology: Click Here

The materials can be fabricated to hold particles with sizes ranging from 5 to 30nm. This can have applications in health, hygiene, fragrance, perfumery, food, agricultural sector.

For More details about the technology: Click Here

Escape Therapeutics has successfully worked on a number of novel and potentially disruptive technologies including peptides/ proteins and some of them are already in the market, either by themselves, or in collaboration, and has also out-licensed portfolios in the past. Their various technologies/ products can be applied for treating conditions such as Type I diabetes, Myocardial infarction and Chronic heart failure, Osteoarthritis, Scleroderma, thermal burn and radiation injury, Hyperpigmentation, Melanoma, Aging, Wound and scar etc. Escape Therapeutics is currently looking for licensing/sale of their Patent Portfolio (including stake in the entity as well) and/or for allied collaborations.

For more details about the technology: Click Here

This breakthrough technology produces functionalized and dispersed multi-walled carbon nanotubes with better mechanical properties resulting in reduced paint coating costs and ownership costs.

For more details about the technology: Click Here

This technology converts bundled carbon nanotubes into discrete, multi-walled CNTs functionalized for use as rubber additive.

For more details about the technology: Click Here

Eutilex has successfully developed Immunotherapeutics platforms which are proven effective as compared to existing solutions. Their various platform technologies can be applied for treating diverse incurable diseases including solid cancer. Eutilex is currently looking for license/ sale of their technology(ies) and/or for allied collaborations.

For more details about the technology: Click Here